Cam Gallagher

Companies

• Opus Genetics, Inc.Board member Nov 9, 2020 to now¹
• Zentalis Pharmaceuticals, Inc.Chief financial officer May 31, 2024 to May 31, 2024²
• Zentalis Pharmaceuticals, Inc.President May 31, 2022 to May 31, 2024³
• Zentalis Pharmaceuticals, Inc.Board member Apr 3, 2020 to May 31, 2024⁴
• Sorrento TherapeuticsBoard member Sep 13, 2012 to Jan 24, 2014⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• OGOpus Genetics, Inc. IRD2,883,111 shares⁶$10.9M at $3.79Sep 8, 2026
• ZPZentalis Pharmaceuticals, Inc. ZNTL633,680 shares⁷$1.5M at $2.29May 31, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 8, 2026Exercised options 784,314 shares at $1.15 of Opus Genetics, Inc.⁶
• Apr 20, 2026Granted 24,367 shares of Opus Genetics, Inc.⁸
• Jan 6, 2026Granted 67,000 shares of Opus Genetics, Inc.⁹
• Dec 31, 2025Granted 33,000 shares of Opus Genetics, Inc.¹⁰
• Dec 29, 2025Bought 83,000 shares at $1.97 of Opus Genetics, Inc.¹⁰
• Dec 29, 2025Bought 81,000 shares at $1.98 of Opus Genetics, Inc.¹⁰
• Aug 25, 2025Granted 869,565 shares at $1.15 of Opus Genetics, Inc.¹¹
• Apr 30, 2025Granted 79,504 shares of Opus Genetics, Inc.¹²
• Mar 24, 2025Granted 784,314 shares of Opus Genetics, Inc.¹³
• Jun 11, 2024Granted 41,143 shares of Opus Genetics, Inc.¹⁴
• May 31, 2024Sold 9,597 shares at $11.98 of Zentalis Pharmaceuticals, Inc.⁷
• Feb 12, 2024Sold 1,173 shares at $11.44 of Zentalis Pharmaceuticals, Inc.¹⁵
• Feb 2, 2024Sold 11,552 shares at $11.54 of Zentalis Pharmaceuticals, Inc.¹⁶
• Feb 1, 2024Granted 192,500 shares of Zentalis Pharmaceuticals, Inc.¹⁶
• Jun 6, 2023Granted 10,976 shares of Opus Genetics, Inc.¹⁷
• May 31, 2023Sold 18,526 shares at $26.21 of Zentalis Pharmaceuticals, Inc.¹⁸
• May 31, 2023Sold 9,242 shares at $26.40 of Zentalis Pharmaceuticals, Inc.¹⁸
• Feb 14, 2023Sold 8,501 shares at $19.96 of Zentalis Pharmaceuticals, Inc.¹⁹
• Feb 13, 2023Sold 3,332 shares at $20.42 of Zentalis Pharmaceuticals, Inc.¹⁹
• Feb 6, 2023Sold 572 shares at $23.04 of Zentalis Pharmaceuticals, Inc.²⁰
• Feb 6, 2023Sold 9,428 shares at $22.22 of Zentalis Pharmaceuticals, Inc.²⁰
• Feb 1, 2023Granted 161,092 shares of Zentalis Pharmaceuticals, Inc.²¹
• Jan 17, 2023Sold 500 shares at $24.87 of Zentalis Pharmaceuticals, Inc.²²
• Jan 17, 2023Sold 9,500 shares at $24.11 of Zentalis Pharmaceuticals, Inc.²²
• Jan 5, 2023Sold 300 shares at $21.46 of Zentalis Pharmaceuticals, Inc.²³